

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Bevacizumab is a targeted cancer medication that helps fight certain types of cancer by cutting off their blood supply. This medicine works by blocking a protein called VEGF that helps tumors grow new blood vessels to feed themselves.
Your doctor might recommend bevacizumab if you have specific cancers like colorectal, lung, kidney, or brain tumors. It's always given through an IV in a hospital or clinic setting, where medical professionals can monitor you closely throughout the treatment.
Bevacizumab is a laboratory-made antibody that targets cancer cells in a very specific way. Think of it as a highly trained guard that recognizes and blocks certain signals that cancer cells use to grow and spread.
This medication belongs to a class of drugs called angiogenesis inhibitors, which means it stops the formation of new blood vessels. Cancer cells need a constant supply of nutrients and oxygen through blood vessels to survive and multiply. By blocking this blood supply, bevacizumab essentially starves the tumor.
The drug is also known by its brand name Avastin and comes as a clear liquid that healthcare providers mix with saline solution. It's considered a monoclonal antibody, which means it's designed to target one specific protein in your body.
Bevacizumab treats several types of advanced cancers, often in combination with other cancer medications. Your oncologist will determine if this treatment is right for your specific situation based on your cancer type and stage.
Here are the main cancers where bevacizumab might help:
Your doctor might also consider bevacizumab for other cancer types in clinical trials or special circumstances. The medication is rarely used alone and typically works alongside chemotherapy drugs to enhance their effectiveness.
Bevacizumab works by targeting a protein called vascular endothelial growth factor, or VEGF for short. This protein acts like a signal that tells your body to create new blood vessels, which is normally a healthy process.
Cancer cells hijack this natural process by producing excess VEGF to build their own blood vessel network. These new vessels deliver oxygen and nutrients that help tumors grow larger and potentially spread to other parts of your body.
When bevacizumab enters your system, it binds to VEGF proteins and prevents them from sending their blood vessel-building signals. This process essentially cuts off the tumor's food supply, causing it to shrink or stop growing.
The medication is considered moderately strong and typically shows effects within a few treatment cycles. However, it works differently than traditional chemotherapy drugs that directly kill cancer cells.
Bevacizumab is always given through an intravenous (IV) line in a hospital, clinic, or cancer treatment center. You cannot take this medication at home or by mouth, as it needs to be carefully prepared and monitored by healthcare professionals.
Your treatment will typically follow this process: First, a nurse will insert an IV line into your arm or access your port if you have one. The medication is then mixed with saline solution and given slowly over 30 to 90 minutes.
Before each infusion, you don't need to avoid food or drink unless your doctor gives you specific instructions. However, staying well-hydrated by drinking plenty of water in the days leading up to treatment can help your body process the medication better.
You'll receive bevacizumab every 2 to 3 weeks, depending on your treatment plan. Each session might take 2 to 4 hours total, including preparation time and monitoring afterward.
The length of your bevacizumab treatment depends on how well your cancer responds and how your body tolerates the medication. Most people receive treatment for several months, though some may need it for a year or longer.
Your oncologist will monitor your progress through regular scans and blood tests to determine when to continue, adjust, or stop treatment. If your cancer shrinks or stops growing without serious side effects, you might continue treatment for an extended period.
Some people may need to pause treatment temporarily if they develop certain side effects, then resume once these issues resolve. Your doctor will work with you to find the right balance between fighting your cancer and maintaining your quality of life.
Like all cancer medications, bevacizumab can cause side effects, though not everyone experiences them. Most side effects are manageable with proper medical care and monitoring.
Common side effects that many people experience include:
These everyday side effects usually improve as your body adjusts to the medication, and your healthcare team has many ways to help manage them.
Less common but more serious side effects require immediate medical attention and include:
Your medical team will monitor you carefully for these more serious effects and teach you warning signs to watch for between treatments.
Rare but serious complications that occur in a small percentage of patients include:
While these rare effects sound concerning, your healthcare team is trained to recognize and manage them quickly if they occur.
Bevacizumab isn't safe for everyone, and your doctor will carefully review your medical history before recommending this treatment. Certain health conditions or circumstances make this medication too risky.
You should not receive bevacizumab if you have:
Your doctor will also exercise extra caution if you have heart disease, blood clotting disorders, or a history of bowel problems. These conditions don't automatically disqualify you from treatment, but they require closer monitoring.
If you're pregnant or breastfeeding, bevacizumab is not recommended as it can harm your developing baby. Your healthcare team will discuss safe contraception methods if you're of childbearing age.
Bevacizumab is most commonly known by its brand name Avastin, which is the original version developed by Genentech. This is the name you'll most likely hear from your healthcare team and see on your treatment paperwork.
Several biosimilar versions of bevacizumab have been approved and may be available at your treatment center. These include Mvasi, Zirabev, and Alymsys, which work the same way as the original Avastin.
Biosimilars are highly similar to the original medication and have the same effectiveness and safety profile. Your doctor or pharmacist might use any of these names when discussing your treatment, but they all refer to the same type of medication.
If bevacizumab isn't right for you or stops working effectively, your oncologist has several alternative treatment options. The best choice depends on your specific cancer type and your overall health condition.
Other angiogenesis inhibitors that work similarly include:
Your doctor might also consider immunotherapy drugs, different chemotherapy combinations, or targeted therapy pills depending on your situation. Each alternative has its own benefits and side effect profile.
Clinical trials often offer access to newer medications that aren't yet widely available. Your oncologist can help you explore these options if standard treatments aren't suitable.
Bevacizumab isn't necessarily better or worse than other cancer medications, but rather serves a different purpose in your treatment plan. It's often most effective when combined with traditional chemotherapy drugs rather than used alone.
Compared to chemotherapy alone, adding bevacizumab can help shrink tumors more effectively and sometimes helps people live longer. However, it also adds potential side effects that your medical team must carefully manage.
The "best" treatment for you depends on many factors including your cancer type, stage, overall health, and personal preferences. Your oncologist will consider all these factors when creating your personalized treatment plan.
Some people do better with bevacizumab combinations, while others might benefit more from different approaches like immunotherapy or targeted therapy pills. There's no one-size-fits-all answer in cancer treatment.
Is Bevacizumab Safe for People With Heart Disease?
Bevacizumab requires extra caution in people with existing heart conditions, but it's not automatically ruled out. Your cardiologist and oncologist will work together to determine if the benefits outweigh the risks for your specific situation.
If you have heart disease, your medical team will monitor your heart function more closely during treatment. They might adjust your dosage, schedule more frequent check-ups, or recommend heart-protective medications alongside your cancer treatment.
What Should I Do If I Accidentally Receive Too Much Bevacizumab?
An overdose of bevacizumab is extremely unlikely since healthcare professionals carefully calculate and administer every dose. The medication is given slowly through an IV while you're being monitored, making accidental overdose nearly impossible.
If you're concerned about your dosage or experience unusual symptoms after treatment, contact your oncology team immediately. They can evaluate your symptoms and provide appropriate care if needed.
What Should I Do If I Miss a Dose of Bevacizumab?
If you miss a scheduled bevacizumab appointment, contact your oncology team as soon as possible to reschedule. They'll determine the best timing for your next dose based on your treatment schedule and how much time has passed.
Don't try to make up for missed doses by scheduling treatments closer together. Your medical team will adjust your treatment plan safely to get you back on track while maintaining the medication's effectiveness.
When Can I Stop Taking Bevacizumab?
You should only stop bevacizumab treatment under your oncologist's guidance, even if you're feeling better. Cancer treatment decisions are complex and based on scan results, blood tests, and your overall response to therapy.
Your doctor will regularly evaluate whether to continue, modify, or stop your treatment based on how well it's working and how you're tolerating it. Some people may need to stop due to side effects, while others might continue for many months if the treatment is effective.
Can I Get Vaccinations While Taking Bevacizumab?
Most routine vaccinations are safe while receiving bevacizumab, but you should always check with your oncology team first. They might recommend timing vaccinations between treatment cycles or avoiding live vaccines during your treatment period.
Your immune system might not respond as strongly to vaccines while on cancer treatment, so your doctor might suggest additional precautions or booster shots. Keep your medical team informed about any vaccines you're considering.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.